Geode Capital Management LLC Has $812.54 Million Stock Position in Humana Inc. $HUM

Geode Capital Management LLC raised its holdings in Humana Inc. (NYSE:HUM) by 0.8% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 3,184,569 shares of the insurance provider’s stock after acquiring an additional 23,732 shares during the period. Geode Capital Management LLC’s holdings in Humana were worth $812,540,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors have also recently bought and sold shares of the company. Montag A & Associates Inc. grew its position in Humana by 1,880.0% in the fourth quarter. Montag A & Associates Inc. now owns 99 shares of the insurance provider’s stock valued at $25,000 after acquiring an additional 94 shares during the last quarter. CoreCap Advisors LLC grew its position in Humana by 54.4% in the fourth quarter. CoreCap Advisors LLC now owns 105 shares of the insurance provider’s stock valued at $27,000 after acquiring an additional 37 shares during the last quarter. Rosenberg Matthew Hamilton grew its position in Humana by 136.0% in the fourth quarter. Rosenberg Matthew Hamilton now owns 118 shares of the insurance provider’s stock valued at $30,000 after acquiring an additional 68 shares during the last quarter. Larson Financial Group LLC grew its position in Humana by 114.1% in the third quarter. Larson Financial Group LLC now owns 152 shares of the insurance provider’s stock valued at $40,000 after acquiring an additional 81 shares during the last quarter. Finally, Fulcrum Asset Management LLP bought a new position in Humana in the third quarter valued at about $42,000. Institutional investors own 92.38% of the company’s stock.

Wall Street Analysts Forecast Growth

HUM has been the topic of a number of research analyst reports. Leerink Partners raised their target price on shares of Humana from $185.00 to $255.00 and gave the company a “market perform” rating in a research report on Thursday, April 30th. Wells Fargo & Company lowered shares of Humana from a “cautious” rating to a “reduce” rating in a research report on Wednesday, May 20th. Wolfe Research lowered shares of Humana from a “strong-buy” rating to a “peer perform” rating in a research report on Wednesday, May 20th. Cantor Fitzgerald initiated coverage on shares of Humana in a research report on Wednesday, May 20th. They issued an “overweight” rating on the stock. Finally, Needham & Company LLC initiated coverage on shares of Humana in a research report on Wednesday, May 20th. They issued a “buy” rating on the stock. Nine investment analysts have rated the stock with a Buy rating, fifteen have assigned a Hold rating and four have issued a Sell rating to the company’s stock. According to MarketBeat.com, the stock currently has a consensus rating of “Hold” and an average target price of $270.48.

Humana Trading Down 0.9%

Shares of NYSE HUM opened at $305.97 on Friday. The company has a debt-to-equity ratio of 0.66, a quick ratio of 1.77 and a current ratio of 1.77. Humana Inc. has a 52-week low of $163.11 and a 52-week high of $315.66. The firm has a 50 day moving average price of $231.96 and a two-hundred day moving average price of $229.04. The stock has a market cap of $36.74 billion, a P/E ratio of 32.72, a price-to-earnings-growth ratio of 2.24 and a beta of 0.68.

Humana (NYSE:HUM) last announced its quarterly earnings results on Wednesday, April 29th. The insurance provider reported $10.31 earnings per share (EPS) for the quarter, beating the consensus estimate of $9.97 by $0.34. Humana had a net margin of 0.82% and a return on equity of 10.45%. The firm had revenue of $39.65 billion during the quarter, compared to analysts’ expectations of $39.37 billion. During the same period in the prior year, the company posted $11.58 EPS. The company’s revenue was up 23.5% on a year-over-year basis. Humana has set its FY 2026 guidance at 9.000- EPS. As a group, equities analysts forecast that Humana Inc. will post 9.01 EPS for the current year.

Humana Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, July 31st. Shareholders of record on Friday, June 26th will be given a $0.885 dividend. This represents a $3.54 annualized dividend and a yield of 1.2%. The ex-dividend date is Friday, June 26th. Humana’s dividend payout ratio is 37.86%.

Humana Profile

Humana Inc (NYSE: HUM) is a health insurance company headquartered in Louisville, Kentucky, that primarily serves individuals and groups across the United States. The company is best known for its Medicare business, offering Medicare Advantage plans and prescription drug (Part D) coverage, alongside a range of commercial and employer-sponsored group health plans. Humana’s products are designed to cover medical, behavioral health and pharmacy needs for members, with particular emphasis on seniors and Medicare-eligible populations.

In addition to traditional insurance products, Humana provides care-management and wellness services intended to support chronic-condition management, preventive care and care coordination.